Astrana Health, Inc.
ASTH
$29.56
-$1.82-5.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -63.86% | -65.45% | -48.94% | -18.90% | -5.88% |
| Total Other Revenue | 49.89% | 32.89% | 25.22% | 20.66% | 22.20% |
| Total Revenue | 46.72% | 29.71% | 22.76% | 19.34% | 21.19% |
| Cost of Revenue | 50.48% | 31.66% | 23.83% | 19.67% | 24.03% |
| Gross Profit | 26.25% | 19.73% | 17.55% | 17.71% | 7.76% |
| SG&A Expenses | 36.87% | 51.80% | 55.96% | 49.74% | 44.97% |
| Depreciation & Amortization | 57.36% | 46.10% | 25.28% | 6.25% | 1.17% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.39% | 33.49% | 26.32% | 21.80% | 25.21% |
| Operating Income | 5.60% | -16.13% | -14.86% | -8.01% | -18.85% |
| Income Before Tax | -10.04% | -15.83% | -7.58% | 7.61% | 3.72% |
| Income Tax Expenses | -3.45% | -38.50% | -43.12% | -21.39% | -21.74% |
| Earnings from Continuing Operations | -13.69% | 0.97% | 25.71% | 33.01% | 26.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -336.51% | 138.96% | 125.11% | 108.79% | 603.16% |
| Net Income | -28.93% | 39.93% | 49.52% | 40.15% | 34.42% |
| EBIT | 5.60% | -16.13% | -14.86% | -8.01% | -18.85% |
| EBITDA | 14.57% | -7.21% | -9.48% | -5.90% | -15.96% |
| EPS Basic | -30.42% | 37.84% | 45.74% | 36.06% | 29.39% |
| Normalized Basic EPS | -30.59% | -6.80% | -15.52% | -15.90% | -11.43% |
| EPS Diluted | -30.91% | 37.52% | 47.66% | 38.18% | 32.26% |
| Normalized Diluted EPS | -30.79% | -6.86% | -14.81% | -14.81% | -9.82% |
| Average Basic Shares Outstanding | 0.96% | 3.92% | 4.21% | 4.52% | 5.22% |
| Average Diluted Shares Outstanding | 1.10% | 4.04% | 3.77% | 3.54% | 3.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 10.81% | 1.96% | 2.16% | 2.29% |